Expression of thrombospondin‐2 as a marker in proliferative diabetic retinopathy
Open Access
- 7 February 2013
- journal article
- Published by Wiley in Acta Ophthalmologica
- Vol. 91 (3) , e169-e177
Abstract
: Purpose: To determine the expression of the endogenous anti‐angiogenic and pro‐fibrotic matricellular protein thrombospondin (TSP)‐2 and its receptors CD36 and CD47 in proliferative diabetic retinopathy (PDR). In addition, we examined the expression of TSP‐2 in the retinas of diabetic rats.Methods: Epiretinal membranes from 14 patients with PDR and nine patients with proliferative vitreoretinopathy were studied by immunohistochemistry. Vitreous samples from 30 PDR and 25 nondiabetic patients were studied by enzyme‐linked immunosorbent assay. Vitreous samples and retinas of rats were examined by Western blotting.Results: In epiretinal membranes, vascular endothelial cells and myofibroblasts expressed TSP‐2, CD36 and CD47. In PDR membranes, significant correlations were observed between numbers of blood vessels expressing the panendothelial cell marker CD34 and numbers of blood vessels and stromal cells expressing TSP‐2, CD36 and CD47. The numbers of blood vessels and stromal cells expressing CD34, TSP‐2, CD36 and CD47 were significantly higher in membranes with active neovascularization when compared with those with quiescent disease. Thrombospondin‐2 levels in vitreous samples from PDR patients were significantly higher than those in control patients without diabetes (p < 0.001). Western blot analysis revealed a significant increase in the expression of intact and cleaved TSP‐2 in vitreous samples from PDR patients and in the retinas of diabetic rats compared to nondiabetic controls.Conclusions: Upregulation of TSP‐2 may be a protective mechanism against inflammation and angiogenesis associated with PDR.Keywords
This publication has 34 references indexed in Scilit:
- Astrocyte-Derived Thrombospondin-2 Is Critical for the Repair of the Blood-Brain BarrierThe American Journal of Pathology, 2011
- CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivoBreast Cancer Research and Treatment, 2010
- Multiplex N-terminome Analysis of MMP-2 and MMP-9 Substrate Degradomes by iTRAQ-TAILS Quantitative ProteomicsMolecular & Cellular Proteomics, 2010
- Thrombospondins function as regulators of angiogenesisJournal of Cell Communication and Signaling, 2009
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and BehaviorScience Signaling, 2009
- Enhanced Angiogenesis and Reduced Contraction in Thrombospondin-2–null Wounds Is Associated With Increased Levels of Matrix Metalloproteinases-2 and −9, and Soluble VEGFJournal of Histochemistry & Cytochemistry, 2008
- Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesisProceedings of the National Academy of Sciences, 2007
- Thrombospondin-based antiangiogenic therapyMicrovascular Research, 2007
- Expression of hypoxia-inducible factor-1 and the protein products of its target genes in diabetic fibrovascular epiretinal membranesBritish Journal of Ophthalmology, 2007
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996